| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8757236 | Chronic Diseases and Translational Medicine | 2018 | 10 Pages |
Abstract
Treatment with 1200â¯mg/day XZK for 8 weeks significantly decreased the atherogenic small LDL subfraction and reduced oxidative stress and inflammatory markers, in addition to affecting the lipid profile, suggesting multiple beneficial effects in coronary artery disease.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Rui-Xia Xu, Yan Zhang, Yuan-Lin Guo, Chun-Yan Ma, Yu-Hong Yao, Sha Li, Xiao-Lin Li, Ping Qing, Ying Gao, Na-Qiong Wu, Cheng-Gang Zhu, Geng Liu, Qian Dong, Jing Sun, Jian-Jun Li,